Trials / Unknown
UnknownNCT01057186
Hypophosphatemic Rickets in Norway
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Haukeland University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to do a follow-up survey of all individuals with hereditary hypophosphatemia in Norway, focusing on manifestations in childhood and adolescence. The investigators also want to study phenotype-genotype associations, and look for new genes, in all forms of hereditary hypo and hyperphosphatemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Alfacalcidol; phosphate. | Individual dosage form and dosage depending on phenotype and underlying cause. |
| DRUG | Sevelamer | Pills. Individual dosage depending on clinical symptoms/phenotype. |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2018-12-01
- First posted
- 2010-01-27
- Last updated
- 2016-08-31
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT01057186. Inclusion in this directory is not an endorsement.